Urinary organic acid excretion by babies born before 33 weeks of gestation

V Walker1, G A Mills

  • 1Clinical Biochemistry, University of Southampton, Southampton General Hospital, U.K.

Clinical Chemistry
|July 1, 1989
PubMed

Insights

This study analyzed urinary organic acids in premature infants to help diagnose metabolic disorders. New methods identified novel metabolites, aiding in understanding infant metabolic health.

Area of Science:

  • Biochemistry
  • Neonatal Medicine
  • Metabolic Disorders

Background:

  • Premature neonates require careful monitoring for metabolic health.
  • Diagnosing inherited organic acid defects is crucial for early intervention.
  • Standard analytical methods are available for metabolic disorder investigations.

Purpose of the Study:

  • To establish a diagnostic basis for inherited organic acid defects in premature neonates.
  • To characterize urinary organic acid profiles in this vulnerable population.
  • To identify novel urinary metabolites in normal neonates.

Main Methods:

  • Analysis of 127 random urine samples from 22 premature infants (25-32 weeks gestation).
  • Sample preparation involved oximation, extraction, and derivatization to trimethylsilyl forms.
  • Gas-liquid chromatography with mass spectrometry (GC-MS) was used for metabolite identification.

Main Results:

  • A wide range of organic acids was detected, with significant individual variability.
  • No significant ketonuria was observed.
  • Three metabolites, 2,3-butanediol, 3-hydroxy-2-butanone (acetoin), and 4-hydroxy-3-methoxyphenyllactic acid, were identified in normal neonate urine for the first time.
  • Increased excretion of 4-hydroxyphenyllactic acid and other phenolic acids was noted during parenteral feeding.

Conclusions:

  • Urinary organic acid profiling is a valuable tool for assessing metabolic status in premature infants.
  • The identified novel metabolites expand the understanding of neonatal metabolism.
  • Variations in metabolite profiles highlight the influence of clinical care and gut microbiome on neonates.

Related Concept Videos

Drug Excretion: Pulmonary and Glandular Routes01:22

Drug Excretion: Pulmonary and Glandular Routes

Gaseous substances like general anesthetics are absorbed and excreted through the lungs via simple diffusion. This process depends on factors such as pulmonary blood flow, respiration rate, and the substance's solubility. Gaseous anesthetics like nitrous oxide with low blood solubility are excreted rapidly, while compounds like alcohol, with high blood and tissue solubility, are excreted slowly.
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The process...
Drug Excretion: Miscellaneous Routes01:10

Drug Excretion: Miscellaneous Routes

Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific substances...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...